Explanation
Denosumab
Denosumabcan beusedforsecondary prevention offractures in osteoporotic patients withamy estimated
glomerularfitrationrate.Thisisgivenasa60 mg subcutaneous injection every sx months.tis
contraindicated in hypocalcaemiaand hypophosphataemia.Denosumab isamonoclonau antibody thattargets
theRANKliqand.Commonside-effects are jointand musce pains.
@1MINENDOCRINE
